ダウンロード数: 830
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
56_361.pdf | 655.46 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 東岡, 雅也 | ja |
dc.contributor.author | 山口, 絵美 | ja |
dc.contributor.author | 高取, 真吾 | ja |
dc.contributor.author | 田中, 充士 | ja |
dc.contributor.author | 興井, 隆 | ja |
dc.contributor.alternative | Higashioka, Masaya | en |
dc.contributor.alternative | Yamaguchi, Emi | en |
dc.contributor.alternative | Takatori, Shingo | en |
dc.contributor.alternative | Tanaka, Mitsushi | en |
dc.contributor.alternative | Kyoi, Takashi | en |
dc.date.accessioned | 2010-08-20T09:57:01Z | - |
dc.date.available | 2010-08-20T09:57:01Z | - |
dc.date.issued | 2010-07 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/123437 | - |
dc.description.abstract | Estracyt® is an antimitotic drugused for the treatment of prostate cancer, and its most common adverse effects are nausea and vomiting. In this study, we investigated the effect of a 5-HT3 receptor antagonist, granisetron, on emesis induced in ferrets by estramustine phosphate sodium (EMP), the active ingredient of Estracyt. To clarify the mechanism of action of EMP-induced emesis, we also investigated the effect of EMP on the release of serotonin (5-HT) in the isolated rat ileum. EMP (3 mg/kg, per os) induced 75.3±10.2 retchingepisodes and 7.5±1.3 vomitingepisodes duringa 2-h observation period. The latency to the first emetic response was 58.0±13.5 min. Granisetron (0.1 mg/kg, per os) administered 1 h before the administration of EMP reduced the number of EMP-induced retchingand vomitingepisodes to 1.3±1.3 and 1.0±1.0, respectively, and prolonged the latency by a factor of almost two. EMP (10−5 and 10−4 M) increased 5-HT release from isolated rat ileum, and 10 −7 M granisetron almost completely inhibited the increase induced by 10−4 M EMP. These results suggest that EMP induces nausea and vomiting via 5-HT release from the ileum, and that 5-HT3 receptor antagonists may be useful to prevent gastrointestinal adverse effects that occur duringtreatment with Estracyt. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.rights | 許諾条件により本文は2011-08-01に公開 | ja |
dc.subject | Estramustine | en |
dc.subject | 5-HT3 receptor antagonist | en |
dc.subject | Emesis | en |
dc.subject | 5-HT (serotonin) | en |
dc.subject.ndc | 494.9 | - |
dc.title | 前立腺癌治療薬エストラムスチン(エストラサイト®)で誘発されるフェレットにおける悪心・嘔吐に対する5-HT3 受容体拮抗薬の効果 | ja |
dc.title.alternative | Effect of the 5-HT3 Receptor Antagonist Granisetron on Estramustine Phosphate Sodium (Estracyt®)-Induced Emesis in Ferrets | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 56 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 361 | - |
dc.identifier.epage | 365 | - |
dc.textversion | publisher | - |
dc.sortkey | 03 | - |
dc.address | 日本新薬株式会社創薬研究所 | ja |
dc.address | 日本新薬株式会社創薬研究所 | ja |
dc.address | 日本新薬株式会社創薬研究所 | ja |
dc.address | 日本新薬株式会社創薬研究所 | ja |
dc.address | 日本新薬株式会社創薬研究所 | ja |
dc.startdate.bitstreamsavailable | 2011-08-01 | - |
dc.address.alternative | Research Laboratories, Nippon Shinyaku Co., Ltd. | en |
dc.address.alternative | Research Laboratories, Nippon Shinyaku Co., Ltd. | en |
dc.address.alternative | Research Laboratories, Nippon Shinyaku Co., Ltd. | en |
dc.address.alternative | Research Laboratories, Nippon Shinyaku Co., Ltd. | en |
dc.address.alternative | Research Laboratories, Nippon Shinyaku Co., Ltd. | en |
dc.identifier.pmid | 20724808 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.56 No.7 |
![](/dspace/image/articlelinker.gif)
このリポジトリに保管されているアイテムはすべて著作権により保護されています。